Cargando…
Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders
Background: Growth hormone (GH) has long been used as adjuvant treatment in ovarian stimulation for in vitro fertilization (IVF), especially in poor responder (PR) patients. However, its clinical efficacy remains unclear, and most studies are underpowered owing to their small sample size with differ...
Autores principales: | Lee, Yi-Xuan, Shen, Meng-Shun, Tzeng, Chii-Ruey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932970/ https://www.ncbi.nlm.nih.gov/pubmed/31920994 http://dx.doi.org/10.3389/fendo.2019.00892 |
Ejemplares similares
-
Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
por: Grisendi, Valentina, et al.
Publicado: (2019) -
What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
por: Blumenfeld, Zeev
Publicado: (2020) -
Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders
por: Zhu, Jinliang, et al.
Publicado: (2020) -
Development and Validation of a Clinical Pregnancy Failure Prediction Model for Poor Ovarian Responders During IVF/ICSI
por: Li, Fangyuan, et al.
Publicado: (2021) -
Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders
por: Liu, Yuan, et al.
Publicado: (2021)